A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy
Clinical trial NCT01229215 · COMPLETED
Trial details
- NCT number
- NCT01229215
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-04-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.